Prednisolone news

All news on Prednisolone (also known as Metacortandracin, Hostacortin, and Deltalen): plants, production capacities, investments and involved companies.

3 June 2026

Johnson & Johnson: nipocalimab lowers SLE disease activity in Phase 2 JASMINE study

Phase 2 data show FcRn blocker nipocalimab reduced SLE activity versus placebo, with larger benefit in autoantibody‑positive patients and no new safety signals.
30 January 2026

Johnson & Johnson's AKEEGA® Gets CHMP Nod for mHSPC with BRCA1/2 Mutations

CHMP backs AKEEGA® for mHSPC with BRCA1/2 mutations, showing improved progression-free survival and manageable safety profile in Phase 3 AMPLITUDE study.

Who will be producing Prednisolone in the future?

Find out with chemXplore Alpha

Learn more